Medication info
Lovastatin 10 mg Tablet (Rosuvastatin Calcium)

Lovastatin 10 mg Tablet (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201404848 · Approved 2014.10.23 · Insurance code 649604430

Summary

Main use
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia; type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. Adjust the maintenance dose as appropriate according to LDL cholesterol levels, treatment goals, and the patient's response, at intervals of 4 weeks or longer; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medication at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score exceeding 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medication is contraindicated in some of these patients.
Child dose
Age 10 ~ 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • increased total cholesterol
  • increased LDL cholesterol
  • elevated Apo-B protein levels
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
View approved original text

This medication is used as an adjunct when dietary control and exercise do not adequately manage primary hypercholesterolemia and mixed dyslipidemia. Additionally, it is used as an adjunct to dietary therapy or lipid-lowering therapy in patients with homozygous familial hypercholesterolemia. This medication helps reduce total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. It is particularly effective in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It also serves as an adjunctive treatment for dietary management in patients with primary dysbetalipoproteinemia. Finally, it is used to reduce the risk of stroke, myocardial infarction, and arterial revascularization in adults with high cardiovascular risk.

How to take

Adult dose

1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia; type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. Adjust the maintenance dose as appropriate according to LDL cholesterol levels, treatment goals, and the patient's response, at intervals of 4 weeks or longer; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medication at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score exceeding 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medication is contraindicated in some of these patients.

Child dose

Age 10 ~ 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to any component of this medication, severely impaired liver function, muscle diseases, severe renal impairment, or pregnant or breastfeeding women should not take this medication. Additionally, caution should be exercised in patients at high risk of muscle-related side effects or those taking certain medications concurrently. This medication may affect liver function, so patients with a history of liver disease or those who consume alcohol heavily should regularly undergo liver function tests. If symptoms such as muscle pain, weakness, or damage occur, the doctor should be notified immediately, and in severe cases, discontinuation of the medication may be necessary. This medication may cause elevated blood sugar levels in some patients, so those at risk for diabetes should periodically monitor their blood sugar. This medication may reach higher concentrations in patients with specific genotypes, requiring dosage adjustment if side effects occur during treatment. Furthermore, this medication can interact with other drugs, so if other medications are being taken, it is essential to inform healthcare professionals. Care should be taken when using with some antiviral agents, antibiotics, immunosuppressants, and fibrate medications. Women of childbearing potential should use appropriate contraception while on this medication, and if pregnancy is confirmed, it should be stopped immediately. Breastfeeding women are also advised against using this medication. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver and muscle function tests are necessary. Finally, this medication may cause dizziness or other symptoms, so caution is advised when driving or operating machinery.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, joint pain, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.